Picard Medical (PMI) Cash & Equivalents (2024 - 2026)

Picard Medical has reported Cash & Equivalents for 3 years, with the latest figure at $121000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents changed N/A year-over-year to $121000.0; the trailing twelve-month figure through Mar 2026 stood at $121000.0 (changed N/A YoY), and the FY2025 full-year result was $7.5 million, up 7661.46% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $121000.0, down from $7.5 million in the prior quarter.
• The five-year high for Cash & Equivalents was $7.5 million in Q4 2025, with the low at $96000.0 in Q4 2024.
• Historically, Cash & Equivalents has averaged $2.2 million across 3 years, with a median of $410000.0 in 2025.
• The largest YoY upside for Cash & Equivalents was 7661.46% in 2025 against a maximum downside of 7661.46% in 2025.
• Picard Medical's Cash & Equivalents stood at $96000.0 in 2024, then soared by 7661.46% to $7.5 million in 2025, then sank by 98.38% to $121000.0 in 2026.
• The last three Cash & Equivalents figures came in at $121000.0 (Q1 2026), $7.5 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.